Safety and Efficacy of Switching to a FDC of B/F/TAF From E/C/F/TAF, E/C/F/TDF, or ATV+RTV+FTC/TDF in Virologically Suppressed HIV-1 Infected Women
Condition(s):HIV-1 InfectionLast Updated:March 4, 2020Completed
Hide Studies Not Open or Pending
Condition(s):HIV-1 InfectionLast Updated:March 4, 2020Completed
Condition(s):Acquired Immunodeficiency Syndrome; HIV InfectionsLast Updated:November 19, 2018Completed
Condition(s):HIV; HIV InfectionsLast Updated:November 19, 2018Completed
Condition(s):HIV; HIV InfectionsLast Updated:March 2, 2020Completed
Condition(s):HIV RiskLast Updated:February 15, 2019Completed
Condition(s):Human Immunodeficiency Virus; Hepatitis C, ChronicLast Updated:November 14, 2022Completed
Condition(s):HIV-1 InfectionLast Updated:December 1, 2020Completed
Condition(s):HIV-1-infectionLast Updated:February 9, 2024Terminated
Condition(s):Insulin ResistanceLast Updated:August 21, 2017Completed
Condition(s):HIV-1-infection; Hepatitis C, Chronic; Methadone Dependence; Opioid Dependence; Bone Diseases, Metabolic; HIV/AIDS; Co-infection; Buprenorphine Dependence; HCV CoinfectionLast Updated:December 24, 2019Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.